Working… Menu

Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (Opti-Q)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01918397
Recruitment Status : Active, not recruiting
First Posted : August 7, 2013
Last Update Posted : March 20, 2019
National Institute of Allergy and Infectious Diseases (NIAID)
Centers for Disease Control and Prevention
Macleods Pharmaceuticals, Ltd
Information provided by (Responsible Party):
Charles R Horsburgh, Boston University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2020